Envisage report cover

Global Antibiotic Resistance Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028

Published Date: Dec 2021

No. of Pages: 171

Status: Published

Report Code: EMR101027

Antibiotic resistance (ABR) happens because of additional and uncontrolled use of antibiotics. Most antibiotics are sold as over-the-counter drugs, with many people using them without receiving prescriptions from a physician. Also, most physicians, especially in emerging countries, prescribe antibiotics for viral diseases without diagnosing the disease properly. All these factors eventually lead to the growth of antibiotic resistance.


Antibiotics are easily available through drugstores, and growing preference for online pharmacies is also increasing the convenience of antibiotic resistance goods from key players. Addressing antibiotic resistance is difficult because patients, physicians, hospitals, pharmaceutical companies, and agricultural users have inadequate incentives to act in ways that would conserve antibiotic effectiveness.


These challenges suggest the simultaneous deployment of multiple strategies: vaccination to prevent infection and reduce request for antibiotics, aggressive hospital infection control, judicious prescribing and cycling of antibiotics, treatment with narrow-spectrum antibiotics, development of new antibiotics, AMR communication strategies, and coordinated federal policies that steward this resource. The development in antibiotic medications shipped in non-industrial nations is boosting the antibiotic resistance market. Increasing level of bacterial contamination has prompted dispatch of different antibiotic medications, accordingly driving the development of the market all around the world.


The interest for antibiotic resistance is increasing because of nonattendance of cognizance or the maltreatment or abuse of antibiotics. The development of the antibiotic resistance industry can be eased back by the rigid authoritative instrument to endorse antibiotic resistance treatments. Moreover, an absence of financial backer worry in the innovative work of resistance treatments to antibiotics will likewise thwart the market for antibiotic resistance.


The classification of antibiotics is based on chemical structures, activity spectrum and action method. The capacity to withstand the infection is known as resistance to antibiotics. Worldwide, this is likely to be a key issue, leading to full-fledged appearance of the global antibiotic resistance market.


Developments in generic drugs and the increasing susceptible aging population are also contributing to the overall growth of this market. The antibiotics market is expected to exhibit significant growth during the forecast period, due to rise in request for new generation antibiotics that can resolve the issue of antimicrobial resistance.


Additionally, growth of innovative approaches for new antibiotics for treating bacterial infections and increase in number of clinical trials supplement the growth of the antibiotics market. Increasing disease burden is compelling government and non-government bodies to invest in R&D initiatives and boost the development of novel antibiotics and helpful regulatory policies to expedite the approval process and research funding.


The associations for the development of antibiotics are expected to lead to the development of a high number of antibiotic drugs in the foreseeable future. Pharmaceutical companies are cooperating for the development of new therapies to reduce the cost burden of the drug development process.


Moreover, the increasing number of public-private collaborations, wherein funding and innovative R&D approaches are providing by public agencies to firms developing antibiotics, is expected to boost the product pipeline. The rising threat of drug resistance and a weak pipeline of new molecules are important to the development of combinational formulations.


Antibiotic medicines refer to medicines used to treat infections by killing bacteria. These are among the most prescribed courses worldwide in fighting bacterial infections, mainly in outpatient antimicrobial resistance would elevate the rate of poverty and impact low-income countries related to the rest of the world settings. The use of antibiotics has saved millions of lives, but its pervasive use to treat any infection, whether serious, minor, or even viral has led to the rise in antibiotic resistance.

Table of Contents


Chapter 1     Executive Summary   16


1.1     Global Antibiotic Resistance Market: Executive Summary  16


1.1.1     Global Antibiotic Resistance Market Revenue, 2015-2028(USD Million)  18


Chapter 2     Research Methodology   19


2.1     Methodology/Research Approach   19


2.1.1     Research Programs/Design   19


2.1.2     Market Size Estimation   20


2.2     Data Source  20


2.2.1     Secondary Sources  20


2.2.1.1     Preliminary data mining  21


2.2.2     Primary Sources  21


2.2.2.1     Data Collection Matrix  23


2.2.3     Statistical model  23


2.2.4     Data Triangulation   24


2.2.5     Report Objectives  24


Chapter 3     Market Outlook   25


3.1     Key Trends  25


3.1.1     Increasing in clinical developments of antibiotic resistance  25


3.2     Market Drivers  26


3.2.1     Rise in incidence of chronic and infectious disease  26


3.3     Market Restraints  28


3.3.1     High medical costs  28


3.4     Market Opportunities  29


3.4.1     The discovery of advanced prospect molecules and introduction of novel combination therapies to treat antibiotic-resistant microbial infections  29


3.5     Market Challenges  30


3.5.1     Time required for the regulatory approval  30


3.6     Impact Analysis of Driver, Restraint, Opportunity and Challenge  31


3.7     Porter’s Five Forces Analysis  32


3.7.1     Bargaining Power of Suppliers: Moderate  32


3.7.2     Bargaining Power of Buyers: Low to Moderate  33


3.7.3     Threat of New Entrants: Moderate  34


3.7.4     Threat of Substitutes: Moderate  35


3.7.5     Competitive Rivalry: Moderate  36


Chapter 4     Impact of COVID-19 on Antibiotic Resistance Market  37


Chapter 5     Global Antibiotic Resistance Market Overview, By Drug Class 2015, 2021 and 2028 (%)  38


5.1     Global Antibiotic Resistance Market Revenue Share, By Drug Class, 2015, 2021 and 2028 (%)  38


5.2     Global Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  39


5.3     Β-Lactam Antibiotics  40


5.3.1     Introduction   40


5.3.2     Global Antibiotic Resistance Market Revenue, By Β-Lactam Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million)  41


5.4     Cephalosporin   42


5.4.1     Introduction   42


5.4.2     Global Antibiotic Resistance Market Revenue, By Cephalosporin, By Drug Class, By Region, 2015 - 2028 (USD Million)  43


5.5     Quinolones Antibiotics  44


5.5.1     Introduction   44


5.5.2     Global Antibiotic Resistance Market Revenue, By Quinolones Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million)  45


5.6     Macrolide Antibiotics  46


5.6.1     Introduction   46


5.6.2     Global Antibiotic Resistance Market Revenue, By Macrolide Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million)  47


5.7     Tetracycline  48


5.7.1     Introduction   48


5.7.2     Global Antibiotic Resistance Market Revenue, By German, By Drug Class, By Region, 2015 - 2028 (USD Million)  49


5.8     Other  50


5.8.1     Introduction   50


5.8.2     Global Antibiotic Resistance Market Revenue, By Other, By Drug Class, By Region, 2015 - 2028 (USD Million)  51


Chapter 6     Global Antibiotic Resistance Market Overview, By Disease 2015, 2021 and 2028 (%)  52


6.1     Global Antibiotic Resistance Market Revenue Share, By Disease, 2015, 2021 and 2028 (%)  52


6.2     Global Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  53


6.3     CABP   54


6.3.1     Introduction   54


6.3.2     Global Antibiotic Resistance Market Revenue, By CABP, By Disease, By Region, 2015 - 2028 (USD Million)  55


6.4     cUTI 56


6.4.1     Introduction   56


6.4.2     Global Antibiotic Resistance Market Revenue, By cUTI, By Disease, By Region, 2015 - 2028 (USD Million)  57


6.5     cIAI 58


6.5.1     Introduction   58


6.5.2     Global Antibiotic Resistance Market Revenue, By cIAI, By Drug Class, By Region, 2015 - 2028 (USD Million)  59


6.6     BSI 60


6.6.1     Introduction   60


6.6.2     Global Antibiotic Resistance Market Revenue, By BSI, By Drug Class, By Region, 2015 - 2028 (USD Million)  61


6.7     Others  62


6.7.1     Introduction   62


6.7.2     Global Antibiotic Resistance Market Revenue, By Others, By Drug Class, By Region, 2015 - 2028 (USD Million)  63


Chapter 7     Global Antibiotic Resistance Market Overview, By Distribution Channel 2015, 2021 and 2028 (%)  64


7.1     Global Antibiotic Resistance Market Revenue Share, By Distribution Channel, 2015, 2021 and 2028 (%)  64


7.2     Global Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  65


7.3     Hospital Pharmacy  66


7.3.1     Introduction   66


7.3.2     Global Antibiotic Resistance Market Revenue, By Hospital Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million)  67


7.4     Retail Pharmacy  68


7.4.1     Introduction   68


7.4.2     Global Antibiotic Resistance Market Revenue, By Retail Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million)  69


7.5     Online Pharmacy  70


7.5.1     Introduction   70


7.5.2     Global Antibiotic Resistance Market Revenue, By Online Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million)  71


Chapter 8     Global Antibiotic Resistance Market Overview, By Geography, 2015, 2021 and 2028 (%)  72


8.1     Global Antibiotic Resistance Market Revenue Share, By Geographic Regions, 2015, 2021 and 2028 (%)  72


8.2     Global Antibiotic Resistance Market Revenue, By Geographic Regions, 2015 - 2028 (USD Million)  73


Chapter 9     North America Antibiotic Resistance Market Overview, By Countries  74


9.1     North America Antibiotic Resistance Market Overview, 2015 - 2028  74


9.1.1     Introduction   74


9.1.2     North America Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  75


9.1.3     North America Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  76


9.1.4     North America Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  77


9.1.5     North America Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028  78


9.1.6     North America Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million)  79


9.1.6.1     U.S. Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  80


9.1.6.2     U.S. Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  81


9.1.6.3     U.S. Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  81


9.1.6.4     Canada Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  82


9.1.6.5     Canada Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  83


9.1.6.6     Canada Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  83


9.1.6.7     Mexico Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  84


9.1.6.8     Mexico Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  85


9.1.6.9     Mexico Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  85


Chapter 10 Europe Antibiotic Resistance Market Overview, By Countries  86


10.1     Europe Antibiotic Resistance Market Overview, 2015 - 2028  86


10.1.1     Introduction   86


10.1.2     Europe Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  87


10.1.3     Europe Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  88


10.1.4     Europe Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  88


10.1.5     Europe Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028  89


10.1.6     Europe Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million)  90


10.1.6.1     Germany Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  91


10.1.6.2     Germany Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  92


10.1.6.3     Germany Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  92


10.1.6.4     UK Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  93


10.1.6.5     UK Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  94


10.1.6.6     UK Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  94


10.1.6.7     France Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  95


10.1.6.8     France Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  96


10.1.6.9     France Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  96


10.1.6.10     Italy Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  97


10.1.6.11     Italy Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  98


10.1.6.12     Italy Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  98


10.1.6.13     Spain Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  99


10.1.6.14     Spain Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  100


10.1.6.15     Spain Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  100


10.1.6.16     Rest of Europe Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  101


10.1.6.17     Rest of Europe Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  102


10.1.6.18     Rest of Europe Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  102


Chapter 11 Asia Pacific Antibiotic Resistance Market Overview, By Countries  103


11.1     Asia Pacific Antibiotic Resistance Market Overview, 2015 - 2028  103


11.1.1     Introduction   103


11.1.2     Asia Pacific Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  105


11.1.3     Asia Pacific Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  106


11.1.4     Asia Pacific Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  106


11.1.5     Asia Pacific Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028  107


11.1.6     Asia Pacific Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million)  108


11.1.6.1     China Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  109


11.1.6.2     China Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  110


11.1.6.3     China Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  110


11.1.6.4     India Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  111


11.1.6.5     India Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  112


11.1.6.6     India Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  112


11.1.6.7     Japan Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  113


11.1.6.8     Japan Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  114


11.1.6.9     Japan Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  114


11.1.6.10     South Korea Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  115


11.1.6.11     South Korea Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  116


11.1.6.12     South Korea Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  116


11.1.6.13     Rest of Asia-Pacific Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  117


11.1.6.14     Rest of Asia-Pacific Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  118


11.1.6.15     Rest of Asia-Pacific Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  118


Chapter 12 Middle East and Africa Antibiotic Resistance Market Overview, By Countries  119


12.1     Middle East and Africa Antibiotic Resistance Market Overview, 2015 - 2028  119


12.1.1     Introduction   119


12.1.2     Middle East and Africa Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  120


12.1.3     Middle East and Africa Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  121


12.1.4     Middle East and Africa Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  121


12.1.5     Middle East and Africa Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028  122


12.1.6     Middle East and Africa Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million)  123


12.1.6.1     GCC Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  124


12.1.6.2     GCC Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  125


12.1.6.3     GCC Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  125


12.1.6.4     South Africa Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  126


12.1.6.5     South Africa Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  127


12.1.6.6     South Africa Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  127


12.1.6.7     ROMEA Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  128


12.1.6.8     ROMEA Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  129


12.1.6.9     ROMEA Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  129


Chapter 13 South America Antibiotic Resistance Market Overview, By Countries  130


13.1     South America Antibiotic Resistance Market Overview, 2015 - 2028  130


13.1.1     Introduction   130


13.1.2     South America Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  131


13.1.3     South America Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  132


13.1.4     South America Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  132


13.1.5     South America Antibiotic Resistance Market Revenue Share, By Countries Analysis, 2015 - 2028  133


13.1.6     South America Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028(USD Million)  134


13.1.6.1     Brazil Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  135


13.1.6.2     Brazil Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  136


13.1.6.3     Brazil Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  136


13.1.6.4     Argentina Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  137


13.1.6.5     Argentina Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  138


13.1.6.6     Argentina Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  138


13.1.6.7     Rest of South America Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million)  139


13.1.6.8     Rest of South America Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million)  140


13.1.6.9     Rest of South America Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million)  140


Chapter 14 Competitive Landscape  141


14.1     Competitive Environment, 2021  141


14.2     Strategic Framework  142


14.2.1     Recent Initiatives  142


Chapter 15 Key Vendor Analysis  143


15.1     Pfizer Inc  143


15.1.1     Company Basic information   143


15.1.2     Company Profile: 143


15.1.3     Financial Overview (USD Billion): 144


15.1.4     Product Benchmarking   144


15.1.5     Recent Developments  144


15.1.6     SWOT Analysis  145


15.2     GlaxoSmithKline plc  146


15.2.1     Company Basic information   146


15.2.2     Company Profile: 146


15.2.3     Financial Overview (USD Billion): 147


15.2.4     Product Benchmarking   147



  • Recent Developments and Initiatives 147


15.2.5     SWOT Analysis  147


15.3     Merck & Co., Inc  149


15.3.1     Company Basic information   149


15.3.2     Company Profile: 149


15.3.3     Financial Overview (USD Billion): 150


15.3.4     Product Benchmarking   150


15.3.5     Recent Developments  150


15.3.6     SWOT Analysis  150


15.4     Baxter Healthcare Corporation   152


15.4.1     Company Basic information   152


15.4.2     Company Profile: 152


15.4.3     Financial Overview (USD Billion): 153


15.4.4     Product Benchmarking   153


15.4.5     Recent Developments  153


15.4.6     SWOT Analysis  153


15.5     Novartis AG   155


15.5.1     Company Basic information   155


15.5.2     Company Profile  155


15.5.3     Financial Overview (USD Billion): 156


15.5.4     Product Benchmarking   156


15.5.5     Recent Developments  156


15.5.6     SWOT Analysis  156


15.6     Abbott Laboratories  158


15.6.1     Company Basic information   158


15.6.2     Company Profile  158


15.6.3     Financial Overview (USD Billion): 159


15.6.4     Product Benchmarking   159


15.6.5     Recent Developments  159


15.6.6     SWOT Analysis  159


15.7     Sanofi S.A. 161


15.7.1     Company Basic information   161


15.7.2     Company Profile  161


15.7.3     Financial Overview (USD Billion): 162


15.7.4     Product Benchmarking   162


15.7.5     Recent Developments  162


15.7.6     SWOT Analysis  163


Chapter 16 Marketing Strategy Analysis, Distributors/Traders  164


16.1     Marketing Channel  164


16.1.1     Direct Marketing   164


16.1.2     Indirect Marketing   164


16.2     Market Positioning   165


16.2.1     Pricing Strategy  165


16.2.2     Brand Strategy  165


16.2.3     Target Client  166


Chapter 17 Future Outlook: Research Conclusion   167


17.1     Global Antibiotic Resistance Market Outlook, 2021 & 2028: Future Outlook  167


17.2     Conclusion   168


 


 


 


List of Tables


TABLE 1     Global Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 40


TABLE 2     Global Antibiotic Resistance Market Revenue, By Β-Lactam Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 42


TABLE 3     Global Antibiotic Resistance Market Revenue, By Cephalosporin, By Drug Class, By Region, 2015 - 2028 (USD Million) 44


TABLE 4     Global Antibiotic Resistance Market Revenue, By Quinolones Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 46


TABLE 5     Global Antibiotic Resistance Market Revenue, By Macrolide Antibiotics, By Drug Class, By Region, 2015 - 2028 (USD Million) 48


TABLE 6     Global Antibiotic Resistance Market Revenue, By German, By Drug Class, By Region, 2015 - 2028 (USD Million) 50


TABLE 7     Global Antibiotic Resistance Market Revenue, By Other, By Drug Class, By Region, 2015 - 2028 (USD Million) 52


TABLE 8     Global Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 54


TABLE 9     Global Antibiotic Resistance Market Revenue, By CABP, By Disease, By Region, 2015 - 2028 (USD Million) 56


TABLE 10     Global Antibiotic Resistance Market Revenue, By cUTI, By Disease, By Region, 2015 - 2028 (USD Million) 58


TABLE 11     Global Antibiotic Resistance Market Revenue, By cIAI, By Drug Class, By Region, 2015 - 2028 (USD Million) 60


TABLE 12     Global Antibiotic Resistance Market Revenue, By BSI, By Drug Class, By Region, 2015 - 2028 (USD Million) 62


TABLE 13     Global Antibiotic Resistance Market Revenue, By Others, By Drug Class, By Region, 2015 - 2028 (USD Million) 64


TABLE 14     Global Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 66


TABLE 15     Global Antibiotic Resistance Market Revenue, By Hospital Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 68


TABLE 16     Global Antibiotic Resistance Market Revenue, By Retail Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 70


TABLE 17     Global Antibiotic Resistance Market Revenue, By Online Pharmacy, By Distribution Channel, By Region, 2015 - 2028 (USD Million) 72


TABLE 18     Global Antibiotic Resistance Market Revenue, By Geographic Regions, 2015 - 2028 (USD Million) 74


TABLE 19     North America Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 76


TABLE 20     North America Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 77


TABLE 21     North America Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 78


TABLE 22     North America Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 80


TABLE 23     U.S. Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 81


TABLE 24     U.S. Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 82


TABLE 25     U.S. Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 82


TABLE 26     Canada Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 83


TABLE 27     Canada Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 84


TABLE 28     Canada Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 84


TABLE 29     Mexico Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 85


TABLE 30     Mexico Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 86


TABLE 31     Mexico Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 86


TABLE 32     Europe Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 88


TABLE 33     Europe Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 89


TABLE 34     Europe Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 89


TABLE 35     Europe Antibiotic Resistance Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 91


TABLE 36     Germany Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 92


TABLE 37     Germany Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 93


TABLE 38     Germany Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 93


TABLE 39     UK Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 94


TABLE 40     UK Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 95


TABLE 41     UK Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 95


TABLE 42     France Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 96


TABLE 43     France Antibiotic Resistance Market Revenue, By Disease, 2015 - 2028 (USD Million) 97


TABLE 44     France Antibiotic Resistance Market Revenue, By Distribution Channel, 2015 - 2028 (USD Million) 97


TABLE 45     Italy Antibiotic Resistance Market Revenue, By Drug Class, 2015 - 2028 (USD Million) 98


TABLE 46     Italy Antibiotic Resistance Market Revenue, By Dis

The Leading Key Players in Antibiotic Resistance Market 1